Cyclooxygenase-2 expression in lung in patients with congenital heart malformations and pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a cause of morbidity in patients with congenital heart disease (CHD). It has been hypothesized that prostanoides participate in the development of PAH. The aim of this study was to show the potential expression of cyclooxygenase-2 (COX-2) in patients with CHD...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 May 2013
|
| In: |
The thoracic and cardiovascular surgeon
Year: 2013, Jahrgang: 61, Heft: 4, Pages: 307-311 |
| ISSN: | 1439-1902 |
| DOI: | 10.1055/s-0033-1337446 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0033-1337446 Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0033-1337446 
|
| Verfasserangaben: | Tsvetomir Loukanov, Christoph Jaschinski, Milen Kirilov, Homa Klimpel, Matthias Karck, Matthias Gorenflo |
| Zusammenfassung: | Pulmonary arterial hypertension (PAH) is a cause of morbidity in patients with congenital heart disease (CHD). It has been hypothesized that prostanoides participate in the development of PAH. The aim of this study was to show the potential expression of cyclooxygenase-2 (COX-2) in patients with CHD and PAH. |
|---|---|
| Beschreibung: | Gesehen am 21.05.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1439-1902 |
| DOI: | 10.1055/s-0033-1337446 |